{"id":769307,"date":"2022-01-28T01:31:51","date_gmt":"2022-01-28T01:31:51","guid":{"rendered":"https:\/\/www.ghanamma.com\/2022\/01\/28\/european-union-regulator-recommends-pfizers-paxlovid-covid-19-pill-for-use-in-at-risk-adults\/"},"modified":"2022-01-28T01:31:51","modified_gmt":"2022-01-28T01:31:51","slug":"european-union-regulator-recommends-pfizers-paxlovid-covid-19-pill-for-use-in-at-risk-adults","status":"publish","type":"post","link":"https:\/\/www.ghanamma.com\/2022\/01\/28\/european-union-regulator-recommends-pfizers-paxlovid-covid-19-pill-for-use-in-at-risk-adults\/","title":{"rendered":"European Union regulator recommends Pfizer's Paxlovid COVID-19 pill for use in at-risk adults"},"content":{"rendered":"

<\/p>\n

<\/div>\n

Jan. 27 (UPI) —<\/span> The European Union’s drugs regulator on Thursday backed Pfizer’s antiviral pill to treat COVID-19.<\/p>\n

The European Medicines Agency issued a statement recommending granting a conditional marketing authorization for Pfizer’s Paxlovid pill to treat COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of severe disease.\n<\/p>\n

\n
Advertisement<\/div>\n<\/div>\n

“The European Commission will now fast-track the decision-making process to grant a decision on the conditional marketing authorization for Paxlovid, allowing this medicine to be marketed across the EU,” the regulator said.<\/p>\n

In December, the agency ruled that the treatment could be used by adults in advance of formal approval.<\/p>\n

The EMA is also reviewing molnupiravir, an anti-viral pill produced by Merck.<\/p>\n

Pfizer said in November that Paxlovid, which works by binding an enzyme to prevent the virus from replicating, cuts severe illness and death attributed to the coronavirus by 89% when combined with a low dose of ritonavir and taken within five days of the onset of symptoms.<\/p>\n

The United States has committed to purchase 10 million courses of Paxlovid and in December, granted emergency use authorization for the pill.<\/p>\n

Canada has also approved the pill for use by adults with mild to moderate COVID-19 symptoms who are at risk of serious disease that may result in hospitalization or death.\n<\/p>\n

\n
Advertisement<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Jan. 27 (UPI) — The European Union’s drugs regulator on Thursday backed Pfizer’s antiviral pill to treat COVID-19. The European Medicines Agency issued a statement recommending granting a conditional marketing authorization for Pfizer’s Paxlovid pill to treat COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of severe disease. […]<\/p>\n","protected":false},"author":1,"featured_media":769308,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56],"tags":[],"class_list":["post-769307","post","type-post","status-publish","format-standard","has-post-thumbnail","category-world"],"_links":{"self":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts\/769307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/comments?post=769307"}],"version-history":[{"count":0,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts\/769307\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/media?parent=769307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/categories?post=769307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/tags?post=769307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}